FDA to cut animal testing in cancer drug development
Source: SeekingAlpha
2026-05-29 10:09:24 ET
More on Merck, Pfizer, etc.
- Merck & Co., Inc. (MRK) Shareholder/Analyst Call - Slideshow
- Pfizer: Reduced TrumpRx/Patent Risks Meet Accretive M&A Efforts - Reiterate Buy
- FQ1 Healthcare Dividend Roundup: Johnson & Johnson Keeps Outshining Pfizer
- These 10 large-cap U.S. stocks rank among the market's cheapest names
- FDA panel backs XFG strain for 2026-27 COVID vaccine update
Read the full article on Seeking Alpha
For further details see:
FDA to cut animal testing in cancer drug development
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
